Suppression of T-Cell Clonal Expansion Drug is released from Anagel(TM) The above is a graph of data demonstrating that an anti-inflammatory drug was released from Anagel™.  Two controls, one containing the polymer from which Anagel™  is formed and the other containing no additive showed no suppression of T-cell response.  Anagel™ and the anti-inflammatory drug it contained, showed significant suppression of T-cell response.  Analysis of variance, using all of the data points, showed efficacy to very high levels of confidence.  These data suggest that the anti-inflammatory compound was released from the polymeric backbone, one step in the long chain of logic necessary to prove the utility of a pharmaceutical preparation.